-76.5% Administrative expenses - 8.4 - 7.2 -16.9% Finance costs - 4.9 - 3.0 -64.3% Profit for the period 40.9 2.4 1619.5% Net Profit 14.6% 1.3% EBITDA (MB) 62.6 9.0 597.5% EBITDA (%) 22.3% 5.1% Earnings

Discussion and Analysis Quarterly Ending September 30, 2020 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited ( the Company) No. 5

Discussion and Analysis Quarterly Ending September 30, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4

Company Limited’s (the “Company”) Board of Directors Meeting No. 1/2022 held on 23 February 2022 passed a resolution to certify the financial statements and the performance of the year 2021 ended 31

Public Company Limited’s (the “Company”) Board of Directors Meeting No. 3/2022 held on 11 May 2022 passed a resolution to certify the financial statements and the performance for the three-month period

Public Company Limited’s (the “Company”) Board of Directors Meeting No. 4/2023 held on 11 May 2023 passed a resolution to certify the financial statements and the performance for the three-month period

Company Limited’s (“Company”) Board of Directors Meeting No. 1/2024 held on 22 February 2024 passed a resolution to certify the financial statements and the performance for the year ended 31 December 2023

Public Company Limited’s (the “Company”) Board of Directors Meeting No. 3/2024 held on 10 May 2024 passed a resolution to certify the financial statements and the performance for the three-month period

expenses 299.76 277.60 (22.16) -7.39% 582.69 565.08 (17.61) -3.02% Other expenses 1.13 18.50 17.37 1537.17% 2.51 27.385 24.88 991.04% Finance costs 5.13 3.20 (1.93) -37.62% 9.14 6.7 (2.44) -26.70% EBITDA

and admin expenses 299.76 277.65 (22.11) -7.38% 582.69 565.09 (17.60) -3.02% Other expenses 1.13 18.53 17.40 1539.82% 2.51 27.39 24.88 991.24% Finance costs 5.13 3.21 (1.92) -37.43% 9.14 6.71 (2.43